Bernstein raised the firm’s price target on Intuitive Surgical (ISRG) to $750 from $740 and keeps an Outperform rating on the shares. The firm notes Q4 EPS of $2.53 grew 14% and beat consensus by 12%, despite a higher-than-expected $70M donation to the Intuitive Foundation. Margins finished strong, with Q4 gross margin of 67.8% and operating margin of 37.3%, 90bps and 160bps ahead of consensus, respectively, Bernstein adds.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target lowered to $590 from $635 at Citi
- Intuitive Surgical: Durable Growth, Expanding Moat, and Attractive Upside Support Buy Rating and $616 Target
- Intuitive Surgical: Durable Growth, Operating Leverage, and Premium-Valuation Upside Through 2026
- Closing Bell Movers: Intel falls 12% on soft guidance
- ISRG Earnings: Intuitive Surgical’s Financial Results Beat Wall Street’s Expectations